A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

Published in:

Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 295, doi. 10.1002/dmrr.2613

By:

• Jung, Chang Hee;
• Park, Cheol‐Young;
• Ahn, Kyu‐Joeng;
• Kim, Nan‐Hee;
• Jang, Hak‐Chul;
• Lee, Moon‐Kyu;
• Park, Joong‐Yeol;
• Chung, Choon‐Hee;
• Min, Kyung‐Wan;
• Sung, Yeon‐Ah;
• Park, Jeong‐Hyun;
• Kim, Sung Jin;
• Lee, Hyo Jung;
• Park, Sung‐Woo

Publication type:

Article